{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:09:29Z","timestamp":1788498569499,"version":"build-2803163510"},"reference-count":12,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,3,17]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.2967\/jnumed.126.272026","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:00:25Z","timestamp":1777561225000},"page":"1037-1040","source":"Crossref","is-referenced-by-count":1,"title":["The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond"],"prefix":"10.2967","volume":"67","author":[{"given":"Aman","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Hendifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"El-Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloisa P.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026070106450720000_67.7.1037.1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijrobp.2020.11.048","article-title":"A framework for patient-centered pathways of care for radiopharmaceutical therapy: an ASTRO consensus document","volume":"109","author":"Buatti","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2026070106450720000_67.7.1037.2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s43441-019-00036-y","article-title":"Review of drugs approved via the 505(b)(2) pathway: uncovering drug development trends and regulatory requirements","volume":"54","author":"Freije","year":"2020","journal-title":"Ther Innov Regul Sci."},{"key":"2026070106450720000_67.7.1037.3","unstructured":"Biosimilars basics for patients. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/drugs\/biosimilars\/biosimilars-basics-patients. Updated August 1, 2024. Accessed September 29, 2025."},{"key":"2026070106450720000_67.7.1037.4","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research. Determining Whether to Submit an ANDA or a 505(b)(2) Application: Guidance for Industry. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/media\/124848\/download. Published May 2019. Accessed September 29, 2025."},{"key":"2026070106450720000_67.7.1037.5","unstructured":"Goldstein B . Overview of the 505(b)(2) regulatory pathway for new drug applications [presentation]. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/media\/156350\/download. Published May 2019. Accessed September 29, 2025."},{"key":"2026070106450720000_67.7.1037.6","unstructured":"Application number 209311Orig1s000 summary review. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/209311Orig1s000SumR.pdf. Accessed February 12, 2026."},{"key":"2026070106450720000_67.7.1037.7","unstructured":"NDA and BLA calendar year approvals. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/drugs\/nda-and-bla-approvals\/nda-and-bla-calendar-year-approvals. Accessed September 29, 2025."},{"key":"2026070106450720000_67.7.1037.8","unstructured":"Abbreviated New Drug Application (ANDA) 203603. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=203603. Accessed November 7, 2025."},{"key":"2026070106450720000_67.7.1037.9","unstructured":"Netspot (kit for the preparation of gallium Ga 68 dotatate injection) for intravenous use. Prescribing Information. Advanced Accelerator Applications website. https:\/\/www.novartis.com\/us-en\/sites\/novartis_us\/files\/netspot.pdf. Revised October 2023. Accessed March 31, 2026."},{"key":"2026070106450720000_67.7.1037.10","unstructured":"Detectnet (copper Cu 64 dotatate injection). Prescribing Information. Curium US LLC. U.S. Food and Drug Administration website. https:\/\/www.curiumpharma.com\/wp-content\/uploads\/Detectnet-PI.pdf. Revised January 2025. Accessed March 31, 2026."},{"key":"2026070106450720000_67.7.1037.11","unstructured":"Locametz (kit for the preparation of gallium Ga 68 gozetotide injection) for intravenous use. Prescribing Information. Novartis Pharmaceuticals Corporation website. https:\/\/www.locametz-hcp.com\/psma-pet-ct\/using-locametz?site=231288-231285GK100342&utm_source=google&utm_mlr=231288-231285&utm_medium=cpc&utm_campaign=google_branded_2023-locametz-hcp-branded-treatment-phrase%3Bs%3Bph%3Bbr%3Bonc%3Bhcp%3Bbr_apr-2024&utm_content=loc_prostate-cancer_kw_n2_indicationgeneric&utm_term=gallium%20Ga%2068%20gozetotide&gclsrc=aw.ds&gad_source=1&gad_campaignid=19005549993&gbraid=0AAAAAoNZQI_SKn0hfl2bIsRRkxwzRRWri&gclid=Cj0KCQjw4a3OBhCHARIsAChaqJMJ2_ZzhitT3gDPoPGetjrtpqnc3O7G4t7LU1j8regj34lxeP3TjpkaAg7TEALw_wcB. Updated April 2025. Accessed March 31, 2026."},{"key":"2026070106450720000_67.7.1037.12","unstructured":"NephroScan (kit for the preparation of technetium Tc 99m succimer injection), for intravenous use. Prescribing Information. Theragnostics, Inc. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214993s000lbl.pdf. Approved February 18, 2022. Accessed March 31, 2026."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:05:15Z","timestamp":1782914715000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.2967\/jnumed.126.272026"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272026","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}